Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the roll-out of Oxevision in mental health hospitals on patient wellbeing.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England has commissioned a rapid evidence review of vision based monitoring systems, which is available at the following link:
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03673-9
These insights have been used to work in partnership with people with lived experience, clinicians, and stakeholders to develop national guidance, which will be published imminently.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve lobular breast cancer outcomes.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Improving early diagnosis of cancer, including lobular breast cancer, is a priority for NHS England. We will improve cancer survival rates and hit all National Health Service cancer waiting time targets, so that no patient waits longer than they should.
The NHS Breast Screening Programme offers all women in England between the ages of 50 years old and their 71st birthday the opportunity to be screened every three years for breast cancer, to help detect abnormalities and intervene early to reduce the number of lives lost to invasive breast cancer.
The Department invests £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.
We are proud to have invested £29 million into the Institute of Cancer Research and the Royal Marsden NIHR Biological Research Centre in 2022, supporting their efforts to strengthen research into cancer, including lobular breast cancer. Wider investments into breast cancer research include a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, including lobular breast cancer.
The NIHR funds research on cancer prevention, detection, diagnosis, and treatment and care, which saves lives. NIHR funds research in response to proposals received and would welcome applications from researchers on lobular breast cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase awareness of sepsis prevention (a) nationally and (b) in each local NHS trust.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Sepsis has no specific diagnostic test and presentation can vary, making it difficult to diagnose. Early intervention can prevent further deterioration of acutely unwell patients, to help mitigate negative outcomes.
Recent evidence suggests that there is high awareness of sepsis among the general public. The Government and its Arm’s Length Bodies are therefore focused on improving the clinical awareness and recognition of sepsis by healthcare professionals, so that unwell and deteriorating patients are identified promptly and started on life-saving treatment. NHS England has launched several training programmes aimed at improving the diagnosis and early management of sepsis. These programmes are regularly reviewed and revised with support from subject matter experts, as new national sepsis guidance is implemented.
Individual National Health Service trusts may also choose to implement additional initiatives on sepsis locally. NHS England is leading the rollout of Martha’s Rule within 143 hospital sites by March 2025. Martha’s Rule will give staff, patients, and families the ability to initiate a rapid review for acute physiological deterioration, which will inform whether further actions are required to give the patient the most appropriate and safe care.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) level and (b) quality of support provided by (i) GPs and the (ii) wider medical profession to women experiencing (A) peri-menopausal and (B) menopausal symptoms.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is committed to prioritising women’s health as we reform the National Health Service. Evidence from the women's health strategy call for evidence in 2021 identified difficulties accessing care due to lack of recognition of symptoms from both women and healthcare professionals, and reluctance of some healthcare professionals to prescribe hormone replacement therapy for menopause symptoms.
A range of information and resources are available to help primary care professionals to support women experiencing menopause symptoms. The Royal College of General Practitioners (RCGP) has a holistic curriculum of training that all general practitioners (GPs) must cover before they are able to pass the examination to become a member of the RCGP and work independently as a GP. There is a specific section on women’s health, including menopause. The National Institute for Health and Care Excellence is also updating its guideline on menopause diagnosis and management.
The Department has also invested £25 million over 2023/24 and 2024/25 to support the establishment of at least one pilot women’s health hub in every integrated care system. These provide more specialist care for women in the community, and many of them also act as a point of training and support for their local GP community. Menopause care is a core service for pilot women’s health hubs.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support social workers.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We support social workers through our existing initiatives such as bursaries, which is the main funding route to support students studying Higher Education Institute courses, and the Assessed Supported Year in Employment, which provides support and assessment for newly qualified social workers.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help improve outcomes for glioblastoma brain tumour patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS England and the Department are taking several steps to help improve outcomes for glioblastoma brain tumour patients. NHS England has worked with the Tessa Jowell Brain Cancer Mission to designate centres of excellence in the management of brain tumours, with nine centres having achieved designation. The Mission has a workstream on training to expand the brain tumour treatment workforce in collaboration between National Health Service bodies, Royal Colleges and charities.
Further to this, in September 2024, the National Institute for Health and Care Research (NIHR) announced new research funding opportunities for brain cancer research, including glioblastoma, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients and a new funding call to generate high quality evidence in brain tumour care, support and rehabilitation.
We are aware of Siobhain McDonagh's campaign, in memory of the late Baroness McDonagh, and are committed to working together to explore options.
We will get the NHS diagnosing cancer, including brain tumours, on time, diagnosing it earlier and treating it faster so more patients survive this horrible set of diseases, and we will improve patients’ experience across the system. To do this, we will address the challenges in diagnostic waiting times, providing the number of CT, MRI and other tests that are needed to reduce cancer waits.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of removing car-parking charges for NHS patients and staff.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
No assessment has been made of the potential merits of removing car-parking charges for National Health Service patients and staff.
All NHS trusts that charge for hospital car parking provide free parking to in-need groups, which include NHS staff working overnight, frequent outpatient attenders, disabled people, and parents of children staying overnight in hospital.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what information his Department holds on regional variations in (a) the speed of diagnosis and (b) health outcomes for blood cancer patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) speed and (b) accuracy of blood cancer diagnoses.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the survival rate of blood cancer patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.